Antibiotic resistance linked to these household products
The study, by Assistant Professor Hui Peng’s research group in the department of chemistry in the Faculty of Arts & Science, was able to show that Triclosan – a chemical often included in household items like hand soaps, toothpastes, and cleaning products to fight off bacteria – is the predominant antibiotic in Ontario sewage sludge. The findings were published in the journal Environmental Science & Technology.

Holly Barrett, a PhD candidate in the department of chemistry, led a study that found that triclosan, found in many common household products, is the predominant antibiotic in Ontario's sewage sludge.
Dan Haves
“Since there are so many different antibiotics in the sewage sludge, we were surprised to find that the majority of antibacterial activity of the sludge could be directly linked to triclosan alone,” says Holly Barrett, a PhD candidate in the Peng group and lead author on the study.
The research was performed by investigating sewage sludge from Ontario’s sewage treatment plants (STPs). As the study notes, STPs are a breeding ground for antibiotic resistant bacteria due to the diverse set of antibiotics that are found there. That’s because after we rinse our household products down the drain, the antibiotic ingredients in those products are transported to STPs where they accumulate.
Among thousands of co-occurring chemicals in the sludge, triclosan was found to be the predominant antibacterial compound impacting E. coli.
Barrett notes in the study that antibiotic resistance is a growing concern. Antibiotic-resistant bacteria – also commonly known as “superbugs” – are strains of bacteria that are not killed by antibiotics. They are produced when continuous exposure to antibiotics causes bacteria to evolve over several generations to survive antibiotic effects. These bacteria can be very dangerous to humans, especially those with impaired immune systems. Between 2014 and 2016, there were 700,000 deaths around the world attributed to antibiotic resistance.
In 2016, the U.S. Food and Drug Administration banned triclosan from being used in antibacterial liquid soaps, and then a year later from being used in topical antiseptics found in health-care settings. Currently, there are limited regulations on triclosan in Canada, and Health Canada deems triclosan as safe for use in a variety of consumer products at specified levels.
“I think our results demonstrate that there is an urgent need for regulatory agencies in Canada to re-evaluate the use of triclosan,” says Barrett.
“It’s still used in thousands of different household and cosmetic products in Canada, as well as in health-care settings. While there are a few regulations in place to restrict the maximum amount of triclosan allowed in consumer products, even very low levels of this chemical may cause antibiotic resistant bacteria to form over time.
Original publication
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

New X-ray technology can improve Covid-19 diagnosis - Patient study demonstrates benefits of dark-field X-ray technology
TcLand Expression appoints its Scientific and Medical Advisory Board dedicated to Rheumatology
New therapeutic approach identified for kidney disease associated with lupus
Monsanto and Complix sign collaboration to bring new technologies to agriculture
Human Genome Science announces positive results of phase 2 clinical trial of Lymphostat-B in systemic lupus

Researchers decode new antibiotic - Combined attack minimizes resistance development
Japan's Ministry of Health, Labour and Welfare grants approval for Actelion's miglustat for the treatment of Niemann-Pick type C disease

How COVID-19 permanently damages the heart - Research team shows for the first time how the inflammation in COVID 19 alters the smallest vessels in the heart

Embryonic development and cancer cell growth - Embryonic factors for reprograming cancer cells

Chemotherapy or not? - Success in researching most effective methods for cancer therapy

Superdex™ 75 Increase, Superdex 200 Increase, Superose™ 6 Increase | Chromatography systems | Cytiva
